EAFCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。EAF遺伝子サイレンサーは、EAF CRISPR/Cas9ノックアウトプラスミドとEAFDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のEAFCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
EAF CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
EAF1 CRISPR/Cas9 KOプラスミド (h) | sc-410221 | h | Gene Knockout | GFP | 0 | ||
EAF1 HDRプラスミド (h) | sc-410221-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
EAF1 Double Nickaseプラスミド (h) | sc-410221-NIC | h | Gene Knockout | Puromycin | 0 | ||
EAF1 Double Nickaseプラスミド (h2) | sc-410221-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
EAF1 CRISPR/Cas9 KOプラスミド (m) | sc-428881 | m | Gene Knockout | GFP | 0 | ||
EAF1 HDRプラスミド (m) | sc-428881-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
EAF1 Double Nickaseプラスミド (m) | sc-428881-NIC | m | Gene Knockout | Puromycin | 0 | ||
EAF1 Double Nickaseプラスミド (m2) | sc-428881-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
EAF2 CRISPR/Cas9 KOプラスミド (h) | sc-407180 | h | Gene Knockout | GFP | 0 | ||
EAF2 HDRプラスミド (h) | sc-407180-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
EAF2 Double Nickaseプラスミド (h) | sc-407180-NIC | h | Gene Knockout | Puromycin | 0 | ||
EAF2 Double Nickaseプラスミド (h2) | sc-407180-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
EAF2 CRISPR/Cas9 KOプラスミド (m) | sc-430651 | m | Gene Knockout | GFP | 0 | ||
EAF2 HDRプラスミド (m) | sc-430651-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
EAF2 Double Nickaseプラスミド (m) | sc-430651-NIC | m | Gene Knockout | Puromycin | 0 | ||
EAF2 Double Nickaseプラスミド (m2) | sc-430651-NIC-2 | m | Gene Knockout | Puromycin | 0 |
EAF CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
EAF1 CRISPR Activationプラスミド (h) | sc-410221-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF1 CRISPR Activationプラスミド (h2) | sc-410221-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF1 Lentiviral Activation Particles (h) | sc-410221-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF1 Lentiviral Activation Particles (h2) | sc-410221-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF1 CRISPR Activationプラスミド (m) | sc-428881-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF1 CRISPR Activationプラスミド (m2) | sc-428881-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF1 Lentiviral Activation Particles (m) | sc-428881-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF1 Lentiviral Activation Particles (m2) | sc-428881-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF2 CRISPR Activationプラスミド (h) | sc-407180-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF2 CRISPR Activationプラスミド (h2) | sc-407180-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF2 Lentiviral Activation Particles (h) | sc-407180-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF2 Lentiviral Activation Particles (h2) | sc-407180-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF2 CRISPR Activationプラスミド (m) | sc-430651-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF2 CRISPR Activationプラスミド (m2) | sc-430651-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF2 Lentiviral Activation Particles (m) | sc-430651-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EAF2 Lentiviral Activation Particles (m2) | sc-430651-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |